Literature DB >> 23875562

TMEM106B and frontotemporal lobar degeneration: can over-expression tell us how reductions are beneficial?

Steven W Barger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23875562      PMCID: PMC4372718          DOI: 10.1111/jnc.12357

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  8 in total

1.  Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.

Authors:  Carlos Cruchaga; Caroline Graff; Huei-Hsin Chiang; Jun Wang; Anthony L Hinrichs; Noah Spiegel; Sarah Bertelsen; Kevin Mayo; Joanne B Norton; John C Morris; Alison Goate
Journal:  Arch Neurol       Date:  2011-01-10

2.  TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.

Authors:  N Finch; M M Carrasquillo; M Baker; N J Rutherford; G Coppola; M Dejesus-Hernandez; R Crook; T Hunter; R Ghidoni; L Benussi; J Crook; E Finger; K J Hantanpaa; A M Karydas; P Sengdy; J Gonzalez; W W Seeley; N Johnson; T G Beach; M Mesulam; G Forloni; A Kertesz; D S Knopman; R Uitti; C L White; R Caselli; C Lippa; E H Bigio; Z K Wszolek; G Binetti; I R Mackenzie; B L Miller; B F Boeve; S G Younkin; D W Dickson; R C Petersen; N R Graff-Radford; D H Geschwind; R Rademakers
Journal:  Neurology       Date:  2010-12-22       Impact factor: 9.910

3.  TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.

Authors:  Alice S Chen-Plotkin; Travis L Unger; Michael D Gallagher; Emily Bill; Linda K Kwong; Laura Volpicelli-Daley; Johanna I Busch; Sebastian Akle; Murray Grossman; Vivianna Van Deerlin; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

4.  TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.

Authors:  Alexandra M Nicholson; Nicole A Finch; Aleksandra Wojtas; Matt C Baker; Ralph B Perkerson; Monica Castanedes-Casey; Linda Rousseau; Luisa Benussi; Giuliano Binetti; Roberta Ghidoni; Ging-Yuek R Hsiung; Ian R Mackenzie; Elizabeth Finger; Bradley F Boeve; Nilüfer Ertekin-Taner; Neill R Graff-Radford; Dennis W Dickson; Rosa Rademakers
Journal:  J Neurochem       Date:  2013-07-01       Impact factor: 5.372

5.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.

Authors:  Nigel J Cairns; Eileen H Bigio; Ian R A Mackenzie; Manuela Neumann; Virginia M-Y Lee; Kimmo J Hatanpaa; Charles L White; Julie A Schneider; Lea Tenenholz Grinberg; Glenda Halliday; Charles Duyckaerts; James S Lowe; Ida E Holm; Markus Tolnay; Koichi Okamoto; Hideaki Yokoo; Shigeo Murayama; John Woulfe; David G Munoz; Dennis W Dickson; Paul G Ince; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2007-06-20       Impact factor: 17.088

6.  Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.

Authors:  Vivianna M Van Deerlin; Patrick M A Sleiman; Maria Martinez-Lage; Alice Chen-Plotkin; Li-San Wang; Neill R Graff-Radford; Dennis W Dickson; Rosa Rademakers; Bradley F Boeve; Murray Grossman; Steven E Arnold; David M A Mann; Stuart M Pickering-Brown; Harro Seelaar; Peter Heutink; John C van Swieten; Jill R Murrell; Bernardino Ghetti; Salvatore Spina; Jordan Grafman; John Hodges; Maria Grazia Spillantini; Sid Gilman; Andrew P Lieberman; Jeffrey A Kaye; Randall L Woltjer; Eileen H Bigio; Marsel Mesulam; Safa Al-Sarraj; Claire Troakes; Roger N Rosenberg; Charles L White; Isidro Ferrer; Albert Lladó; Manuela Neumann; Hans A Kretzschmar; Christine Marie Hulette; Kathleen A Welsh-Bohmer; Bruce L Miller; Ainhoa Alzualde; Adolfo Lopez de Munain; Ann C McKee; Marla Gearing; Allan I Levey; James J Lah; John Hardy; Jonathan D Rohrer; Tammaryn Lashley; Ian R A Mackenzie; Howard H Feldman; Ronald L Hamilton; Steven T Dekosky; Julie van der Zee; Samir Kumar-Singh; Christine Van Broeckhoven; Richard Mayeux; Jean Paul G Vonsattel; Juan C Troncoso; Jillian J Kril; John B J Kwok; Glenda M Halliday; Thomas D Bird; Paul G Ince; Pamela J Shaw; Nigel J Cairns; John C Morris; Catriona Ann McLean; Charles DeCarli; William G Ellis; Stefanie H Freeman; Matthew P Frosch; John H Growdon; Daniel P Perl; Mary Sano; David A Bennett; Julie A Schneider; Thomas G Beach; Eric M Reiman; Bryan K Woodruff; Jeffrey Cummings; Harry V Vinters; Carol A Miller; Helena C Chui; Irina Alafuzoff; Päivi Hartikainen; Danielle Seilhean; Douglas Galasko; Eliezer Masliah; Carl W Cotman; M Teresa Tuñón; M Cristina Caballero Martínez; David G Munoz; Steven L Carroll; Daniel Marson; Peter F Riederer; Nenad Bogdanovic; Gerard D Schellenberg; Hakon Hakonarson; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Genet       Date:  2010-02-14       Impact factor: 38.330

7.  The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function.

Authors:  Owen A Brady; Yanqiu Zheng; Kira Murphy; Marshall Huang; Fenghua Hu
Journal:  Hum Mol Genet       Date:  2012-11-06       Impact factor: 6.150

Review 8.  The genetics and neuropathology of frontotemporal lobar degeneration.

Authors:  Anne Sieben; Tim Van Langenhove; Sebastiaan Engelborghs; Jean-Jacques Martin; Paul Boon; Patrick Cras; Peter-Paul De Deyn; Patrick Santens; Christine Van Broeckhoven; Marc Cruts
Journal:  Acta Neuropathol       Date:  2012-08-14       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.